146 related articles for article (PubMed ID: 18181659)
1. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.
Baraldi PG; Tabrizi MA; Gessi S; Borea PA
Chem Rev; 2008 Jan; 108(1):238-63. PubMed ID: 18181659
[No Abstract] [Full Text] [Related]
2. Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
González MP; Terán C; Teijeira M
Med Res Rev; 2008 May; 28(3):329-71. PubMed ID: 17668454
[TBL] [Abstract][Full Text] [Related]
3. [Recent adenosine antagonists].
Suzuki F; Shimada J
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1277-92. PubMed ID: 7568926
[No Abstract] [Full Text] [Related]
4. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
5. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
[TBL] [Abstract][Full Text] [Related]
6. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
[TBL] [Abstract][Full Text] [Related]
7. Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease.
Benarroch EE
Neurology; 2008 Jan; 70(3):231-6. PubMed ID: 18195269
[No Abstract] [Full Text] [Related]
8. A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
van Veldhoven JP; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Struensee-Link R; Beukers MW; Brussee J; IJzerman AP
Bioorg Med Chem; 2008 Mar; 16(6):2741-52. PubMed ID: 18258439
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines.
Raghu Prasad M; Raghuram Rao A; Shanthan Rao P; Rajan KS; Meena S; Madhavi K
Eur J Med Chem; 2008 Mar; 43(3):614-20. PubMed ID: 17602796
[TBL] [Abstract][Full Text] [Related]
10. A quantitative analysis of binding affinities of ligands active at adenosine receptors.
Sharma RC; Singh P; Ojha TN; Tiwari S
Drug Des Discov; 1994 Nov; 12(2):169-77. PubMed ID: 9116170
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A(2A) receptor antagonists.
Cole AG; Stauffer TM; Rokosz LL; Metzger A; Dillard LW; Zeng W; Henderson I
Bioorg Med Chem Lett; 2009 Jan; 19(2):378-81. PubMed ID: 19059776
[TBL] [Abstract][Full Text] [Related]
12. A new chemical tool (C0036E08) supports the role of adenosine A(2B) receptors in mediating human mast cell activation.
Buceta M; Domínguez E; Castro M; Brea J; Alvarez D; Barcala J; Valdés L; Alvarez-Calderón P; Domínguez F; Vidal B; Díaz JL; Miralpeix M; Beleta J; Cadavid MI; Loza MI
Biochem Pharmacol; 2008 Oct; 76(7):912-21. PubMed ID: 18687311
[TBL] [Abstract][Full Text] [Related]
13. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.
Peppard WJ; Schuenke CD
Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524
[TBL] [Abstract][Full Text] [Related]
14. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Trevitt J; Kawa K; Jalali A; Larsen C
Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
[TBL] [Abstract][Full Text] [Related]
16. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A(2B) receptor antagonists.
Nieto MI; Balo MC; Brea J; Caamaño O; Cadavid MI; Fernández F; Mera XG; López C; Rodríguez-Borges JE
Bioorg Med Chem; 2009 May; 17(9):3426-32. PubMed ID: 19346133
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
[TBL] [Abstract][Full Text] [Related]
20. Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
Trevitt J; Vallance C; Harris A; Goode T
Pharmacol Biochem Behav; 2009 May; 92(3):521-7. PubMed ID: 19463269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
